Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope

Retrovirology

Volumn 5, Issue , 2008, Pages

  Lamb, Daniel ^a   Schüttelkopf, Alexander W ^b   Van Aalten, Daan M F ^b   Brighty, David W ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LEUCINE; MEMBRANE PROTEIN; VIRUS PROTEIN; ANTIVIRUS AGENT; PEPTIDE; VIRUS ENVELOPE PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BOVINE LEUKEMIA VIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENETIC CONSERVATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MEMBRANE FUSION; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS PATHOGENESIS; AMINO ACID SUBSTITUTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; SYNTHESIS;

BOVINAE; BOVINE LEUKEMIA VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CONSERVED SEQUENCE; HELA CELLS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA VIRUS, BOVINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 51649086395     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-70     Document Type: Article

References (51)

1. Anonymous Human T-cell Lymphotropic viruses Human Immunodeficiency viruses and human T-cell lymphotropic viruses Group IW: IARC Monographs 1996, 67:261-390.
2. Cann AJ Chen ISY Human T-cell Leukaemia virus types I and II Fields Virology Philadelphia: Lippincott-Raven 3 1996, 2:1849-1880. [Fields BN, Knipe, D.M., Howley, P.M., Channock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (Series Editor)
3. Gillet N Florins A Boxus M Burteau C Nigro A Vandermeers F Balon H Bouzar AB Defoiche J Burny A Mechanisms of leukemogenesis induced by bovine leukemia virus: Prospects for novel anti-retroviral therapies in human 2007, 4:16. 17362524 1839114
4. Johnston ER Albritton LM Radke K Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein J Virol 2002, 76:10861-10872. 136609 12368329 10.1128/JVI.76.21.10861-10872.2002
5. Gallaher WR Ball JM Garry RF Martin-Amedee AM Montelaro RC A general model for the surface glycoproteins of HIV and other retroviruses AIDS Res Hum Retroviruses 1995, 11:191-202. 7742034
6. Kim FJ Seiliez I Denesvre C Lavillette D Cosset FL Sitbon M Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus J Biol Chem 2000, 275:23417-23420. 10.1074/ jbc.C901002199 10851227
7. Gatot JS Callebaut I Van Lint C Demonte D Kerkhofs P Portetelle D Burny A Willems L Kettmann R Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo J Virol 2002 , 76:7956-7967. 155115 12134000 10.1128/JVI.76.16.7956-7967.2002
8. Kim FJ Battini JL Manel N Sitbon M Emergence of vertebrate retroviruses and envelope capture Virology 2004, 318:183-191. 10.1016/ j.virol.2003.09.026 14972546
9. Kim FJ Manel N Garrido EN Valle C Sitbon M Battini JL HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding Retrovirology 2004 , 1:41. 539286 15575958 10.1186/1742-4690-1-41
10. Johnston ER Radke K The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions J Virol 2000, 74:2930-2935. 111788 10684314 10.1128/ JVI.74.6.2930-2935.2000
11. Wallin M Ekstrom M Garoff H Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion Embo J 2004, 23:54-65. 1271652 14685283 10.1038/sj.emboj.7600012
12. Wallin M Ekstrom M Garoff H The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization J Virol 2005 , 79:1678 -1685. 544115 15650193 10.1128/ JVI.79.3.1678-1685.2005
13. Weissenhorn W Dessen A Calder LJ Harrison SC Skehel JJ Wiley DC Structural basis for membrane fusion by enveloped viruses Mol Membr Biol 1999, 16:3-9. 10.1080/096876899294706 10332732
14. Eckert DM Kim PS Mechanisms of viral membrane fusion and its inhibition Annu Rev Biochem 2001, 70:777-810. 10.1146/annurev.biochem.70.1.777 11395423
15. Park HE Gruenke JA White JM Leash in the groove mechanism of membrane fusion Nat Struct Biol 2003, 10:1048-1053. 10.1038/nsb1012 14595397
16. Kobe B Center RJ Kemp BE Poumbourios P Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins Proc Natl Acad Sci USA 1999, 96:4319-4324. 16330 10200260 10.1073/pnas.96.8.4319
17. Chan DC Fass D Berger JM Kim PS Core structure of gp41 from the HIV envelope glycoprotein Cell 1997, 89:263-273. 10.1016/ S0092-8674(00)80205-6 9108481
18. Malashkevich VN Chan DC Chutkowski CT Kim PS Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides Proc Natl Acad Sci USA 1998, 95:9134-9139. 21304 9689046 10.1073/ pnas.95.16.9134
19. Malashkevich VN Singh M Kim PS The trimer-of-hairpins motif in membrane fusion: Visna virus Proc Natl Acad Sci USA 2001, 98:8502-8506. 37465 11447278 10.1073/pnas.151254798
20. Pinon JD Kelly SM Price NC Flanagan JU Brighty DW An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein J Virol 2003, 77:3281-3290. 149751 12584351 10.1128/ JVI.77.5.3281-3290.2003
21. Mirsaliotis A Nurkiyanova K Lamb D Kuo CW Brighty DW An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function J Gen Virol 2007, 88:660-669. 10.1099/vir.0.82390-0 17251585
22. Mirsaliotis A Lamb D Brighty DW Non-helical Leash and α-helical Structures Determine the Potency of a Peptide Antagonist of Human T Cell Leukaemia Virus Entry J Virol 2008, 82:4965-4973. 10.1128/JVI.02458-07 18305034
23. Sagara Y Inoue Y Shiraki H Jinno A Hoshino H Maeda Y Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides J Virol 1996, 70:1564-1569. 189978 8627675
24. Wild C Oas T McDanal C Bolognesi D Matthews T A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition Proc Natl Acad Sci USA 1992, 89:10537-10541. 50374 1438243 10.1073/pnas.89.21.10537
25. Wild C Greenwell T Matthews T A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion AIDS Res Hum Retroviruses 1993, 9:1051-1053. 8312047
26. Lambert DM Barney S Lambert AL Guthrie K Medinas R Davis DE Bucy T Erickson J Merutka G Petteway SR Jr Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion Proc Natl Acad Sci USA 1996, 93:2186-2191. 39932 8700906 10.1073/ pnas.93.5.2186
27. Rapaport D Ovadia M Shai Y A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses Embo J 1995, 14:5524-5531. 394666 8521809
28. Dokhelar MC Pickford H Sodroski J Haseltine WA HTLV-I p27rex regulates gag and env protein expression J Acquir Immune Defic Syndr 1989, 2:431-440. 2677310
29. Hope TJ McDonald D Huang XJ Low J Parslow TG Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: Essential residues near the amino terminus J Virol 1990, 64:5360-5366. 248585 2120472
30. Churchill MJ Moore JL Rosenberg M Brighty DW The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells J Virol 1996, 70:5786-5790. 190592 8709194
31. Jassal SR Lairmore MD Leigh-Brown AJ Brighty DW Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells Virus Res 2001, 78:17-34. 10.1016/ S0168-1702(01)00279-9 11520577
32. Singh M Berger B Kim PS LearnCoil-VMF: Computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins J Mol Biol 1999, 290:1031-1041. 10.1006/jmbi.1999.2796 10438601
33. Thompson JD Higgins DG Gibson TJ CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res 1994, 22:4673-4680. 308517 7984417 10.1093/nar/22.22.4673
34. Lindahl EHB Spoel van der D Gromacs 3.0: A package for molecular simulation and trajectory analysis J Mol Mod 2001, 7:306-317.
35. Weissenhorn W Carfi A Lee KH Skehel JJ Wiley DC Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain Mol Cell 1998, 2:605-616. 10.1016/S1097-2765(00)80159-8 9844633
36. Malashkevich VN Schneider BJ McNally ML Milhollen MA Pang JX Kim PS Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution Proc Natl Acad Sci USA 1999, 96:2662-2667. 15825 10077567 10.1073/pnas.96.6.2662
37. Melikyan GB Markosyan RM Hemmati H Delmedico MK Lambert DM Cohen FS Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion J Cell Biol 2000, 151:413-423. 2192659 11038187 10.1083/jcb.151.2.413
38. Hadlock KG Rowe J Perkins S Bradshaw P Song GY Cheng C Yang J Gascon R Halmos J Rehman SM Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46 J Virol 1997, 71:5828-5840. 191838 9223472
39. Mirsaliotis A Nurkiyanova K Lamb D Woof JM Brighty DW Conformation-specific Antibodies targeting the trimer-of-hairpins motif of the HTLV-1 Trans-membrane glycoprotein recognise viral envelope but fail to neutralise viral entry J Virol 2007. 1900303 17376912
40. Mirsaliotis A Nurkiyanova K Lamb D Kuo CW Brighty DW Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses J Biol Chem 2007, 282:36724-36735. 10.1074/jbc.M706827200 17940280
41. Maerz AL Center RJ Kemp BE Kobe B Poumbourios P Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure J Virol 2000, 74:6614-6621. 112171 10864675 10.1128/JVI.74.14.6614-6621.2000
42. Chen J Skehel JJ Wiley DC N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil Proc Natl Acad Sci USA 1999, 96:8967-8972. 17716 10430879 10.1073/pnas.96.16.8967
43. Kim FJ Manel N Boublik Y Battini JL Sitbon M Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain J Virol 2003, 77:963-969. 140806 12502812 10.1128/JVI.77.2.963-969.2003
44. Poon B Chen IS Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication J Virol 1998, 72:1959-1966. 109488 9499049
45. Platt EJ Kuhmann SE Rose PP Kabat D Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region J Virol 2001, 75:12266-12278. 116123 11711617 10.1128/ JVI.75.24.12266-12278.2001
46. Saha K Yan H Nelson JA Zerhouni-Layachi B Infection of human and non-human cells by a highly fusogenic primary CD4-independent HIV-1 isolate with a truncated envelope cytoplasmic tail Virology 2005, 337:30-44. 10.1016/j.virol.2005.04.003 15914218
47. Zwick MB Saphire EO Burton DR gp41: HIV's shy protein Nat Med 2004, 10:133-134. 10.1038/nm0204-133 14760422
48. Miller MD Geleziunas R Bianchi E Lennard S Hrin R Zhang H Lu M An Z Ingallinella P Finotto M A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope Proc Natl Acad Sci USA 2005, 102:14759-14764. 1253587 16203977 10.1073/pnas.0506927102
49. Kerkhofs P Gatot JS Knapen K Mammerickx M Burny A Portetelle D Willems L Kettmann R Long-term protection against bovine leukaemia virus replication in cattle and sheep J Gen Virol 2000, 81:957-963. 10725421
50. Ibuki K Funahashi SI Yamamoto H Nakamura M Igarashi T Miura T Ido E Hayami M Shida H Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene J Gen Virol 1997, 78:147-152. 9010298
51. Chan DC Chutkowski CT Kim PS Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target Proc Natl Acad Sci USA 1998, 95:15613-15617. 28092 9861018 10.1073/pnas.95.26.15613